Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1970 1
1971 5
1972 5
1973 4
1974 4
1975 5
1976 5
1977 6
1978 3
1979 6
1980 6
1981 3
1982 12
1983 16
1984 5
1985 12
1986 8
1987 11
1988 9
1989 16
1990 17
1991 13
1992 19
1993 17
1994 10
1995 22
1996 19
1997 15
1998 14
1999 19
2000 26
2001 20
2002 17
2003 20
2004 22
2005 21
2006 20
2007 13
2008 19
2009 9
2010 5
2011 3
2012 15
2013 11
2014 7
2015 8
2016 8
2017 8
2018 6
2019 6
2020 11
2021 4
2022 16
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

589 results
Results by year
Filters applied: . Clear all
Page 1
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.
Glienke W, Dragon AC, Zimmermann K, Martyniszyn-Eiben A, Mertens M, Abken H, Rossig C, Altvater B, Aleksandrova K, Arseniev L, Kloth C, Stamopoulou A, Moritz T, Lode HN, Siebert N, Blasczyk R, Goudeva L, Schambach A, Köhl U, Eiz-Vesper B, Esser R. Glienke W, et al. Among authors: lode hn. Front Immunol. 2022 Mar 24;13:839783. doi: 10.3389/fimmu.2022.839783. eCollection 2022. Front Immunol. 2022. PMID: 35401506 Free PMC article.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: lode hn. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Seitz CM, Flaadt T, Mezger M, Lang AM, Michaelis S, Katz M, Syring D, Joechner A, Rabsteyn A, Siebert N, Troschke-Meurer S, Zumpe M, Lode HN, Yang SF, Atar D, Mast AS, Scheuermann S, Heubach F, Handgretinger R, Lang P, Schlegel P. Seitz CM, et al. Among authors: lode hn. Front Immunol. 2021 Jul 22;12:690467. doi: 10.3389/fimmu.2021.690467. eCollection 2021. Front Immunol. 2021. PMID: 34367149 Free PMC article. Clinical Trial.
Impact of Bacterial Toxins in the Lungs.
Lucas R, Hadizamani Y, Gonzales J, Gorshkov B, Bodmer T, Berthiaume Y, Moehrlen U, Lode H, Huwer H, Hudel M, Mraheil MA, Toque HAF, Chakraborty T, Hamacher J. Lucas R, et al. Among authors: lode h. Toxins (Basel). 2020 Apr 2;12(4):223. doi: 10.3390/toxins12040223. Toxins (Basel). 2020. PMID: 32252376 Free PMC article. Review.
Hospital-acquired pneumonia in Europe.
Torres A, Ewig S, Lode H, Carlet J. Torres A, et al. Among authors: lode h. Eur Respir J. 2009 May;33(5):951-2. doi: 10.1183/09031936.00004509. Eur Respir J. 2009. PMID: 19407045 Free article. No abstract available.
Gemifloxacin for community-acquired pneumonia.
Lode HM, Schmidt-Ionas M, Stahlmann R. Lode HM, et al. Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779. Expert Opin Investig Drugs. 2008. PMID: 18447602 Review.
The pharmacokinetics of sultamicillin.
Lode H, Hampel B, Bruckner G, Koeppe P. Lode H, et al. APMIS Suppl. 1989;5:17-22. APMIS Suppl. 1989. PMID: 2660866 Review.
The clinical positioning of telavancin in Europe.
Masterton R, Cornaglia G, Courvalin P, Lode HM, Rello J, Torres A. Masterton R, et al. Among authors: lode hm. Int J Antimicrob Agents. 2015 Mar;45(3):213-20. doi: 10.1016/j.ijantimicag.2014.12.006. Epub 2014 Dec 24. Int J Antimicrob Agents. 2015. PMID: 25600892 Review.
[Community-acquired pneumonia].
Kemmerich B, Rahlwes M, Vogel-Hartmann H, Bartmann K, Höffken G, Berntsson E, Ruckdeschel G, Wagner J, Lode H. Kemmerich B, et al. Among authors: lode h. Dtsch Med Wochenschr. 1989 Sep 29;114(39):1471-7. doi: 10.1055/s-2008-1066784. Dtsch Med Wochenschr. 1989. PMID: 2791899 German.
589 results